Most IVF ‘add-on’ treatments have no effect on fertility or remain unproven, study says
IVF ‘add-ons’—from supplements to procedures—face growing scrutiny as new research finds most lack proven fertility benefits
📍 The outcome
A major review published in *The Lancet* found most IVF "add-on" treatments lack proven benefits for fertility, with studies showing insufficient evidence to support their use. Coverage highlighted widespread availability of these services in countries like Australia, often marketed to patients despite limited backing from research.
The story did not develop further in subsequent reporting, leaving the focus on the findings without updates on regulatory or industry responses.
Epilogue added 43d ago, after coverage quieted.
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A major review published in *The Lancet* concludes that the vast majority of complementary treatments marketed to IVF patients—such as acupuncture, nutritional supplements, and specialized lab procedures—have **no demonstrated effect on pregnancy rates** or remain unproven. Coverage highlights how these ‘add-ons’ are widely promoted despite limited scientific backing, with some clinics offering them as optional upgrades to standard IVF protocols. Outlets including *The New York Times*, *The Guardian*, and *The Sydney Morning Herald* note that patients—often desperate for higher success rates—are frequently pressured into purchasing add-ons with unclear benefits.
The *Science Media Centre España* and *India Today* frame the findings as a call for stricter regulation and transparency in fertility clinics. What to watch next: Regulatory bodies may tighten guidelines on IVF marketing practices, and clinics could face increased scrutiny over how they advertise unproven treatments. Patient advocacy groups may push for clearer disclaimers, while fertility specialists could see a shift in industry standards—though no immediate policy changes have been announced.
Coverage does not yet specify whether insurers will adjust coverage for these treatments.
Synthesized by headlinez.news from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (88% supported) Updated 46d ago.
Who reported it (8)
- Most ‘add-on’ IVF treatments do not improve fertility, study says The Independent · 46d ago
- There is insufficient evidence that most complementary treatments for in vitro fertilization improve fertility Science Media Centre España · 46d ago
- Lancet review questions IVF add-ons as most show little proven benefit India Today · 46d ago
- 'Desperate' IVF patients offered treatments with no proven fertility benefits SBS Australia · 46d ago
- IVF add-ons are common in Australia, but there's no proof most work Australian Broadcasting Corporation · 46d ago
- IVF ‘add-ons’ don’t work or have little evidence when it comes to pregnancy, new Australian research finds SMH.com.au · 46d ago
- Services Sold to Boost I.V.F. Odds Backed by Little Evidence, Study Finds The New York Times · 46d ago
- Most IVF ‘add-on’ treatments have no effect on fertility or remain unproven, study says The Guardian · 46d ago
Quick answers
What are ‘IVF add-ons’?
Complementary treatments marketed alongside standard IVF procedures, such as acupuncture, nutritional supplements, specialized embryo culture media, or genetic testing upgrades. These are often sold as ways to improve pregnancy chances but lack robust clinical evidence.
Are these treatments banned or restricted?
No. The review does not call for bans, but it raises concerns about **misleading marketing**. Clinics can still offer add-ons, but patients may lack full transparency about their efficacy. Coverage suggests regulatory scrutiny could increase, but no outright prohibitions have been announced.
Which countries are most affected?
Australia and Spain have seen significant local coverage, with research highlighting high usage rates. The *Lancet* review’s findings are global, but regional differences in clinic practices and regulations may influence how quickly changes occur.
Topics
Related trends
Heart disease in women: Women with THIS common hormonal condition are at higher risk, new study finds
A newly published Lancet study reclassifies PCOS as PMOS and links the hormonal condition to an increased risk of heart disease in women.
Women with common health condition face higher risk ofheart disease
A formal name change from PCOS to PMOS highlights clinical findings linking the condition to a significantly increased risk of cardiovascular disease.
Researchers uncover possible cause of muscle pain from widely used cholesterol medication
New research challenges long-held assumptions about statin side effects—muscle pain may not be the drug’s fault
Huge Survey Finds the Truth About What mRNA Vaccines Do to the Human Body
Global review of billions of mRNA doses confirms safety, effectiveness—and hints at future medical breakthroughs
Alcohol is one of the most dangerous drugs, yet its presence is ubiquitous in social settings and celebrations
Recent scientific discourse and the International Alcohol Control Online Symposium are shifting the public health narrative surrounding alcohol consumption.
Few sunscreens meet safety standards, new report says
Only a fraction of sunscreens pass new safety benchmarks, raising alarms as summer heat intensifies globally